Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Fluticasone propionate; Salmeterol xinafoate
Genesis Pharmaceuticals Ltd
R03AK06
Fluticasone propionate; Salmeterol xinafoate
250microgram/1dose ; 50microgram/1dose
Inhalation powder
Inhalation
No Controlled Drug Status
Caution - AMP level prescribing advised
BNF: 03020000; GTIN: 5060014446084